Accès ouvert déclaré
2024
article
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors
Jack Phan, Jivianne K. Lee, Peter H. Hwang, Christos Georgalas, Ricardo L. Carrau, Waleed M. Abuzeid, Claudio Callejas, Edward C. Kuan, Iacopo Dallan, Brian C. Lobo, Richard R. Orlandi, Bradford A. Woodworth, John R. de Almeida, Amber Luong, Mohemmed Khan, James N. Palmer, Satyan B. Sreenath, Masaru Ishii, Ian Witterick, Loren S. Michel, Bradley A. Gross, David G. Pfister, Adam J. Kimple, Rakesh K. Chandra, William C. Yao, Pavol Šurda, Chien‐Fu Yeh, Charles S. Ebert, Olabisi Sanusi, Tran B. Locke, Paolo Castelnuovo, Gary L. Gallia, Derrick T. Lin, Roi Dagan, Katharina Stölzel, Todd T. Kingdom, Adam J. Folbe, Jean Anderson Eloy, Martin J. Citardi, Kyle K. VanKoevering, Nancy J. Fischbein, Zara M. Patel, Justin H. Turner, Thibaut Van Zele, Angelo Paolo Dei Tos, Mario Turri‐Zanoni, Michelle Alonso‐Basanta, Ehab Y. Hanna, Roy R. Casiano, Jessica W. Grayson, Stephen Hernandez, Brent A. Senior, Eric W. Wang, Shorook Na'ara, Devyani Lal, Meha G. Fox, Jean‐Yves Blay, Marco Ferrari, Christian Betz, Mathew Geltzeiler, Shirley Y. Su, Erin L. McKean, Svetomir N. Markovic, Gretchen M. Oakley, Brian D. Thorp, Matt Lechner, Corinna G. Levine, Christina H. Fang, Mindy Rabinowitz, Alfred Marc Iloreta, Jeremiah A. Alt, Hien Le, Nobuyoshi Otori, Ahmad R. Sedaghat, Kazuhiro Omura, Stéphanie Wong, Camila Dassi, Zhenxiao Huang, Kristine A. Smith, Diana Bell, Daniel M. Beswick, Garret Choby, Valerie J. Lund, Ruifeng Guo, Tae‐Bin Won, Ashleigh A. Halderman, Anne E. Getz, Philippe Schafhausen, Sarah K. Wise, Daniel W. Nuss, Peter‐John Wormald, Paolo Antognoni, Ying‐Ju Kuo, Marc Rosen, Paul A. Gardner, David W. Kennedy, Aria Jafari, Lester D.�R. Thompson, C. Arturo Solares, Manuel Bernal‐Sprekelsen, Michael E. Ivan, Nyall R. London, Mihir K. Bhayani, William M. Mendenhall, Aldo Cassol Stamm, Patrick K. Ha, Zoukaa Sargi, Vasileios Chatzinakis, Bobby A. Tajudeen, Ming‐Ying Lan, Satish Govindaraj, Jin‐Ching Lin, Adam L. Holtzman, Raj Shrivastava, Borislav A. Alexiev, Wytske J. Fokkens, Ryan Rimmer, Naweed I. Chowdhury, Gianluca Dalfino, Baran D. Sumer, Nithin D. Adappa, Nyssa Fox Farrell, Peter Papagiannopoulos, Marilene B. Wang, Raymond K. Tsang, G. Matnjani, Claire Hopkins, Aaron M. Udager, Eric Lamarre, Simon Chen, Ivan H. El‐Sayed, John M. DelGaudio, Alkis J. Psaltis, Raj Sindwani, Marc A. Cohen, Richard J. Harvey, Stacey T. Gray, Rodney J. Schlosser, Benjamin S. Bleier, Zhigang Huang, Timothy L. Smith, Pete S. Batra, Gurston Nyquist, Anna Knisely, Cem Meço, Victor Lee, Juliana Bonilla‐Velez, Kevin C. Welch, Piero Nicolai, James J. Evans, Murugappan Ramanathan, Kelly R. Magliocca, Charles C. L. Tong, Nancy Y. Lee, Alexander G. Chiu, Ian M. Humphreys, Carl H. Snyderman, Jordon G. Grube
0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés
Rattachement africain : us.
Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology-based topics spanning the field. METHODS: In accordance with prior International Consensus Statement on Allergy and Rhinology documents, ICSNT assigned each topic as an Evidence-Based Review with Recommendations, Evidence-Based Review, and Literature Review based on the level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses format, and completed sections underwent a thorough and iterative consensus-building process. The final document underwent rigorous synthesis and review prior to publication. RESULTS: The ICSNT document consists of four major sections: general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology-based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention. CONCLUSION: As an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
La source scientifique ouverte est momentanément indisponible.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Les sujets associés
Sinusitis and nasal conditionsHead and Neck Surgical Oncology